Logo image of EPZM

EPIZYME INC (EPZM) Stock Analyst Earnings Estimates

NASDAQ:EPZM - Nasdaq - US29428V1044 - Common Stock - Currency: USD

1.47  -0.02 (-1.34%)

After market: 1.47 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
EPZM revenue by date.EPZM revenue by date.
23.8M
9.68%
15.76M
-33.78%
37.427M
137.48%
45.377M
21.24%
74.901M
65.06%
126.186M
68.47%
206.31M
63.50%
344.058M
66.77%
EBITDA
YoY % growth
EPZM ebitda by date.EPZM ebitda by date.
-176.3M
-38.75%
-221.44M
-25.60%
-232.746M
-5.11%
-119.804M
48.53%
N/AN/AN/AN/A
EBIT
YoY % growth
EPZM ebit by date.EPZM ebit by date.
-177.14M
-38.27%
-225.42M
-27.26%
-237.992M
-5.58%
-186.002M
21.85%
-178.683M
3.93%
-159.071M
10.98%
-167.579M
-5.35%
-180.072M
-7.46%
Operating Margin
EPZM operating margin by date.EPZM operating margin by date.
-744.29%-1,430.33%-635.88%-409.90%-238.56%-126.06%-81.23%-52.34%
EPS
YoY % growth
EPZM eps by date.EPZM eps by date.
-1.88
-8.05%
-2.29
-21.81%
-2.41
-5.24%
-1.37
43.15%
-1.17
14.62%
-0.97
17.03%
-1.10
-13.55%
-1.28
-15.83%

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 22 Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth
-0.32
47.47%
-0.35
27.61%
-0.21
43.63%
-0.21
-2.00%
-0.21
32.04%
-0.21
39.61%
-0.18
14.29%
-0.17
19.05%
-0.16
23.81%
-0.15
28.57%
Revenue
Q2Q % growth
12.189M
134.36%
13.927M
20.24%
16.32M
87.67%
18.462M
-32.93%
21.012M
72.38%
23.97M
72.11%
27.642M
69.38%
31.518M
70.72%
35.802M
70.39%
40.392M
68.51%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-44.302M
30.93%
-43.862M
14.48%
N/AN/AN/AN/AN/AN/AN/AN/A

Recent Earnings VS Estimates Surprises ()
PeriodReportedEstimateDifferenceSurprise
Q2 2022
Q2Q % growth
-0.21
66.67%
-0.370.1642.93%
Q1 2022
Q2Q % growth
-0.38
44.93%
-0.35-0.03-7.18%
Q4 2021
Q2Q % growth
-0.49
24.62%
-0.540.059.36%
Q3 2021
Q2Q % growth
-0.60
-9.09%
-0.49-0.11-22.55%
Q2 2021
Q2Q % growth
-0.63
-8.62%
-0.630.00-0.16%
Q1 2021
Q2Q % growth
-0.69
-35.29%
-0.59-0.10-17.85%
Q4 2020
Q2Q % growth
-0.65
-10.17%
-0.60-0.05-9.03%
Q3 2020
Q2Q % growth
-0.55
-37.50%
-0.620.0710.75%
Q2 2020
Q2Q % growth
-0.58
-9.43%
-0.620.046.60%
Q1 2020
Q2Q % growth
-0.51
-41.67%
-0.760.2532.81%
Q4 2019
Q2Q % growth
-0.59 -0.51-0.08-14.80%
Q3 2019
Q2Q % growth
-0.40 -0.540.1425.50%
Q2 2019
Q2Q % growth
-0.53 -0.540.011.15%
Q1 2019
Q2Q % growth
-0.36 -0.470.1123.79%
EPZM Yearly EPS VS EstimatesEPZM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -1 -2 -3
Recent Revenue VS Estimates Surprises

Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .

PeriodReportedEstimateDifferenceSurprise
Q2 2022
Q2Q % growth
27.528M
111.59%
10.404M17.124M164.59%
Q1 2022
Q2Q % growth
8.696M
13.97%
10.631M-1.935M-18.20%
Q4 2021
Q2Q % growth
11.583M
38.22%
8.425M3.158M37.48%
Q3 2021
Q2Q % growth
5.201M
45.69%
13.445M-8.244M-61.32%
Q2 2021
Q2Q % growth
13.01M
426.72%
8.897M4.113M46.22%
Q1 2021
Q2Q % growth
7.63M
465.19%
6.857M772.877K11.27%
Q4 2020
Q2Q % growth
8.38M
95.34%
6.315M2.065M32.69%
Q3 2020
Q2Q % growth
3.57M
-37.59%
5.537M-1.967M-35.53%
Q2 2020
Q2Q % growth
2.47M
-58.14%
4.39M-1.92M-43.73%
Q1 2020
Q2Q % growth
1.35M
-82.89%
3.754M-2.404M-64.04%
Q4 2019
Q2Q % growth
4.29M 3.145M1.145M36.41%
Q3 2019
Q2Q % growth
5.72M 5.44M280.003K5.15%
Q2 2019
Q2Q % growth
5.9M 1.785M4.115M230.53%
Q1 2019
Q2Q % growth
7.89M 2.199M5.691M258.74%
EPZM Yearly Revenue VS EstimatesEPZM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A